Last reviewed · How we verify
NCT07514988
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment
NA trial testing Sirolimus-coated DCB in Acute Coronary Syndromes (ACS) in 60 participants. Not yet recruiting.
31 December 2027
Quick facts
| Lead sponsor | China National Center for Cardiovascular Diseases |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 May 2026 |
| Primary completion | 31 December 2027 |
| Estimated completion | 1 July 2028 |
| Sites | 1 location across China |
Drugs / interventions tested
- Sirolimus-coated DCB
- Paclitaxel-coated DCB
Conditions studied
- Acute Coronary Syndromes (ACS) — all drugs for Acute Coronary Syndromes (ACS) →
Sponsor
China National Center for Cardiovascular Diseases — full company profile →
Who can join
Adults 18 to 80, any sex, with Acute Coronary Syndromes (ACS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate and compare the local inflammatory responses and plaque healing characteristics between sirolimus-coated and paclitaxel-coated coronary drug-coated balloons in patients with acute coronary syndrome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07514988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Coronary Syndromes (ACS)
Currently open trials in the same condition.
- NCT07259252 — Influenza Vaccination After Acute Coronary Syndrome · NA · recruiting
- NCT06855537 — Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques · Phase 4 · recruiting
- NCT07182799 — Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance · active not recruiting
- NCT06853626 — One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care · NA · recruiting
- NCT07512778 — IVUS-Guided vs Angiography-Guided PCI in Acute Coronary Syndrome · NA · recruiting
Other China National Center for Cardiovascular Diseases trials
Trials by the same sponsor.
- NCT07476456 — Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death · not yet recruiting
- NCT07302659 — Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG · NA · recruiting
- NCT07482683 — Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach · not yet recruiting
- NCT06787430 — Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI · Phase 4 · not yet recruiting
- NCT07308496 — Computed Tomography-derived Fractional Flow Reserve vs. Angiographic Quantitative Flow Ratio in Management of Patients W · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07514988 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China National Center for Cardiovascular Diseases
- Last refreshed: 7 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07514988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing